Skip to main content
. 2016 May 5;6(3):263–275. doi: 10.1136/bmjspcare-2015-000958

Table 2.

Characteristics of studies included in the review

Lead author Year Country Description of sample Study design Number of family carers at baseline in
Intervention Control (UC or APC)
Ferrell 1995 USA Family carers of hospital outpatients aged 60+ years with cancer-related pain duration ≥3 months; prescribed opioid analgesia SGPP 50
Wells 2003 USA Family carers of hospital outpatients with cancer pain of onset or escalation in last 3 months; managed by analgesia; life expectancy >6 months SGPP then 3-arm RCT of follow-up
a. Patient-initiated
b. Nurse-initiated
64
a. 21
b. 19
−24 (UC)
Keefe 2005 USA Family carers of hospice and hospital outpatients with advanced cancer diagnosis; disease-related pain (worst >3 BPI); life expectancy <6 months 2-arm RCT 41 37 (UC)
Lin 2006 Taiwan Family carers of hospital outpatients with cancer pain taking oral analgesics 2-arm RCT 31 30 (UC)
Ward 2009 USA Family carers of hospital outpatients with cancer diagnosis, reporting moderate to severe pain in past 2 weeks; performance status score indicating out of bed >50% of waking hours 3-arm RCT
a. Dyad
b. Patient only
a. 51
b. 53
57 (UC)
Capewell 2010 UK Family carers of patients receiving palliative care from hospital outpatient clinics or community teams; living at home; pain from active cancer rated ≥3 on 0–10 scale SGPP 10
Vallerand 2010 USA Family carers of patients with cancer pain receiving care from home care nurses (not hospice nurses) Cluster RCT 24 22 (UC)
Valeberg 2013 Norway Family carers of hospital outpatients with cancer diagnosis and radiographic evidence of bone metastasis; pain ≥2.5 on 1–10 scale; KPS ≥50 2-arm RCT 58 54 (APC+ booklet)

Study design: RCT, randomised controlled trial; SGPP, single group pretest and post-test design.

Control: APC, attention placebo control; UC, usual care.

BPI, Brief Pain Inventory.